Massachusetts Chapter of the American College of Surgeons

MCACS Home MCACS Home Past & Future Meetings Past & Future Meetings

Back to 2026 Display Posters


Robotic Cholecystectomy with Intraoperative Cholangioscopy for Common Bile Duct Exploration: A Single-Institution Case Series
Maria Fernanda Queiroz Ferreira1, Zeynep Bilgili1, Daniel Bent1, Charles Parsons1 1Beth Israel Deaconess Medical Center, Boston, MA

Background: Single-stage management of choledocholithiasis during cholecystectomy avoids the burden of two-stage ERCP-based approaches. Outcomes data for SpyGlass cholangioscopy in robotic cholecystectomy remain limited, especially in patients with altered anatomy limiting ERCP access. The 2025 SAGES guidelines identify SpyGlass as an option for intraoperative stone management in bypass-type anatomy, though without supporting outcomes data. Methods: Single-institution retrospective series of patients undergoing robotic cholecystectomy with intraoperative cholangioscopy at Beth Israel Deaconess Medical Center (January 2024–April 2026). Procedures were performed on da Vinci Xi and 5 platforms with transcystic SpyGlass access. The primary outcome was common bile duct (CBD) stone clearance. Secondary outcomes included operative time, estimated blood loss (EBL), length of stay (LOS), complications, and postoperative ERCP. Results: Eight patients (median age 67.5 years, 75% female, ASA 2–3) underwent the procedure. Four had prior bariatric surgery with altered biliary anatomy. Two had prior ERCP with incomplete clearance and indwelling stents. CBD stones were confirmed in 6/8 patients; two were negative explorations despite suspicious imaging. Complete intraoperative clearance was achieved in 5/6 confirmed cases; one patient with a 15-mm impacted stone required postoperative ERCP. Median operative time was 256 minutes (204–405), EBL 40 mL (20–1000), and LOS 3.5 days (0–8). There were no bile leaks, open conversions, or biliary-related readmissions. Conclusion: Robotic cholecystectomy with intraoperative SpyGlass cholangioscopy is a feasible and effective approach to choledocholithiasis, including in patients with altered anatomy or prior failed ERCP. These findings support its consideration as a viable option for stone clearance in gastric bypass patients.
Back to 2026 Display Posters